Cyclopharm (ASX:CYC) Book Value per Share: A$0.24 (As of Dec. 2025)


ASX:CYC Cyclopharm Ltd ASX:CYC
45 GF Score
Price A$0.53
GF Value A$0.83
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Cyclopharm Book Value per Share?

Cyclopharm ASX:CYC +2.94% 45 Book Value per Share is A$0.24 as of Dec. 2025. GuruFocus rates ASX:CYC with a GF Score™ of 45/100 and a GF Value™ of A$0.83 (Possible Value Trap). The stock has 7 warning signs investors should review.

Cyclopharm's book value per share for the quarter that ended in Dec. 2025 was A$0.24.

During the past 12 months, Cyclopharm's average Book Value Per Share Growth Rate was -36.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -14.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Cyclopharm was 23.60% per year. The lowest was -25.50% per year. And the median was -3.00% per year.

Cyclopharm's current price is A$0.525. Its book value per share for the quarter that ended in Dec. 2025 was A$0.24. Hence, today's PB Ratio of Cyclopharm is 2.15.

During the past 13 years, the highest P/B Ratio of Cyclopharm was 14.55. The lowest was 1.64. And the median was 4.39.


Cyclopharm  (ASX:CYC) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Cyclopharm Book Value per Share Related Terms


Cyclopharm Book Value per Share Historical Data

* Premium members only.

The historical data trend for Cyclopharm's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyclopharm Book Value per Share Chart

Cyclopharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.39 0.34 0.38 0.24

Cyclopharm Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.43 0.38 0.33 0.24

ASX:CYC vs MCK, CAH, COR: Book Value per Share Comparison

For the Medical Distribution subindustry, Cyclopharm's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyclopharm PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cyclopharm's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cyclopharm's PB Ratio falls into.


ASX:CYC
45GF Score
Cyclopharm Ltd ASX:CYC
Book Value per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cyclopharm Book Value per Share Calculation

Cyclopharm's Book Value Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(27.11-0.00)/111.14
=0.24

Cyclopharm's Book Value Per Share for the quarter that ended in Dec. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(27.11-0.00)/111.14
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of A$0.24 mean?
Cyclopharm (ASX:CYC) has a Book Value per Share of A$0.24 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Cyclopharm and its competitors.
Is Cyclopharm's Book Value per Share too high?
Cyclopharm's current Book Value per Share is A$0.24. Overall, Cyclopharm has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cyclopharm's Book Value per Share compare to MCK and CAH?
Cyclopharm's Book Value per Share of A$0.24 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Distribution company?
A good Book Value per Share depends on the Medical Distribution industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Cyclopharm and its competitors. Cyclopharm's current Book Value per Share is A$0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyclopharm stock overvalued right now?
Based on GuruFocus' analysis, Cyclopharm (ASX:CYC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.83, compared to a current price of A$0.53 — trading 36.7% below its estimated fair value. The current Book Value per Share is A$0.24. Cyclopharm's overall GF Score™ is 45/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Cyclopharm (ASX:CYC), the current Book Value per Share is A$0.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cyclopharm (ASX:CYC) Overvalued in 2026?

Based on GuruFocus' analysis, Cyclopharm stock appears to be undervalued. The current stock price of A$0.53 is trading 36.7% below its estimated GF Value™ of A$0.83. GuruFocus considers Cyclopharm to be Possible Value Trap.

Key valuation signals for ASX:CYC:

  • Book Value per Share: A$0.24
  • GF Value™: A$0.83 vs. price of A$0.53 (36.7% below fair value)
  • GF Score™: 45/100 with 7 warning signs

No single metric tells the full story. See the ASX:CYC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cyclopharm Business Description

Address 1 The Crescent, Unit 4, Kingsgrove, Sydney, NSW, AUS, 2208
Cyclopharm Ltd is a health technology company offering solutions related to functional lung ventilation imaging. Its proprietary product Technegas is a broad-spectrum diagnostic lung imaging technology product for the visualisation of pulmonary ventilation and lung function. The company sells its products to healthcare institutions and medical professionals. Maximum revenue is generated from its Technegas products and services, which include the sale of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. Geographically, the company generates maximum revenue from its business in Europe, and the rest from Asia Pacific, Canada, the USA, and other regions.
45GF Score

Get the complete analysis for ASX:CYC

Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.53
Price
A$0.83
GF Value